Yesterday, FDA announced modifications to the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone (Mifeprex–Danco Labs) that enable pharmacies to become certified to dispense this FDA-approved drug to patients with a prescription, as long as they comply with the certification requirements.

On October 3, 2022, the National Academy of Medicine (NAM) published the National Plan for Health Workforce Well-Being.

WASHINGTON, DC – Today, The American Pharmacists Association officially kicked off American Pharmacists Month (APhM). It all started in October, 1925. For one week, radio stations across the country broadcasted special programming to highlight the profession of pharmacy.

(WASHINGTON, DC) Ilisa Bernstein, PharmD, JD, FAPhA, interim executive vice president and CEO of the American Pharmacists Association (APhA) released the following statement regarding HHS Secretary Becerra signing a Public Readiness and Emergency Preparedness (PREP) Act declaration that grants pharmacists the authority to administer monkeypox vaccines.  

WASHINGTON, DC—The American Medical Association (AMA), American Pharmacists Association (APhA), American Society of Health-System Pharmacists (ASHP), and National Community Pharmacists Association (NCPA) are concerned about state laws that limit patients’ access to medically necessary medications and impede physicians and pharmacists from using their professional judgment.